Aurora Cannabis Inc T.ACB

Alternate Symbol(s): ACB | T.ACB.WS.U

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by codyesson Jan 19, 2018 4:03pm

436 Views

Post# 27397295

RE:huge!!

GOING TO BE A VERY GOOD MONDAY! END OF DAY TRADE SAW THIS.

MasterBeartooth wrote: TORONTO, Jan 19 (Reuters) - Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to acquire both companies in a friendly deal, people familiar with the situation told Reuters on Friday.

The move comes after an attempt by Aurora, Canada’s second-biggest listed cannabis producer, to buy CanniMed in an all-stock bid capped at C$24, was met with resistance from the target.

A representative of CanniMed declined to comment, citing an agreement on Thursday that prevented CanniMed and Aurora from making public statements about a potential transaction.

A Newstrike representative did not immediately respond to an emailed request for comment.

Separately, CanniMed has been pushing ahead with plans to buy Newstrike, with the latter’s shareholders voting overwhelmingly in favour of the deal on Wednesday. CanniMed on Thursday postponed its own shareholder vote on the deal to Jan. 25 from Jan. 23 to discuss a possible transaction with Aurora.

With this latest development, both those bids would be scrapped and replaced with a new friendly agreement, according to the people.

Under Aurora’s initial bid, if CanniMed were to buy Newstrike, Aurora’s offer would not proceed.

Under both scenarios, Aurora is prepared to pay a higher price for CanniMed and would look to use its own stock, which has been on a tear alongside the rest of the Canadian cannabis industry.

The new transaction, which would give Aurora control of both CanniMed and Newstrike, could be announced as early as Monday, the people said, cautioning there is no certainty an agreement would be reached.

The people declined to be identified because they were not authorized to speak publicly about the talks.

"We said from the beginning that we’d be happy to sit down for friendly, collaborative discussions, so we’re going in with an open mind and seeing what they have to say," Aurora Chief Corporate Officer Cam Battley told Reuters. "Perhaps there’s an opportunity to do something on a friendly basis." (Reporting by John Tilak and Nichola Saminather; Editing by Denny Thomas and Matthew Lewis)